ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1229

Is NOD2-Associated Autoinflammatory Disease Remotely Related to Familial Mediterranean Fever or Continuum of It?

Min Shen1, Bo Shen2 and Qingping Yao3, 1Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH, 2Gastroenterology, Cleveland Clinic, Cleveland, OH, 3Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Familial Mediterranean fever

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose

NOD2-associated autoinflammatory disease (NAID) is a newly described autoinflammatory disease characterized by periodic fever, dermatitis, polyarthritis, gastrointestinal and sicca symptoms. It is genotypically associated with NOD2. Its clinical phenotype may superficially resemble familial Mediterranean fever (FMF). We report a case series to illustrate the similarities and differences between these two autoinflammatory diseases.

Methods

Three patients with NAID or FMF were cared for by the authors between 2012 and 2014, and their phenotypes and genotypes were retrospectively studied. Genetic testing for MEFV and NOD2 mutations was performed.

Results

The clinical phenotypes and genotypes of these patients are summarized (Table). Patient 1 presented with recurrent fever, abdominal pain/diarrhea, chest pain, and arthralgia since the age of 5 years. Her symptoms responded well to colchicine, and FMF was diagnosed in the presence of heterozygous K695R. Patient 2 is the niece of patient 1 and presented with symptoms since the age of 17 years and shared the similar phenotypes with her aunt except the presence of recurrent erythematous patches of the skin and longer lasting gastrointestinal symptoms. FMF was suspected, but she had a transiently mild response to colchicine.  Genetic testing identified the NOD2 mutations IVS8+158 and R702W and negative MEFV. NAID was diagnosed with a complete response to oral sulfasalazine. Patient 3 is a man and presented with recurrent fever and abdominal pain/diarrhea since the age of 17 years, with mild response to colchicine. Genetic testing identified heterozygous M694V in the MEFV and NOD2 mutation IVS8+158.

Conclusion

Both NAID and FMF appear similar phenotypically, but they are distinct. The symptoms can last longer than 3 days, and spongiotic dermatitis is common in NAID, whereas erysipelas-like erythema with sparse infiltrate on the lower extremities is a feature of FMF. NAID does not respond to colchicine. Both MEFV and NOD2 genes are located on chromosome 16 and share similar gene structures. This case study suggests that these two diseases could be remotely related.


Disclosure:

M. Shen,
None;

B. Shen,
None;

Q. Yao,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-nod2-associated-autoinflammatory-disease-remotely-related-to-familial-mediterranean-fever-or-continuum-of-it/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology